(Bloomberg) -- Apple Inc. will begin selling versions of its Series 9 and Ultra 2 watches without a blood oxygen feature in the US, following a legal setback in its patent dispute with Masimo Corp.Most Read from BloombergChina Weighs Stock Market Rescue Package Backed by $278 BillionIndia Tops Hong Kong as World’s Fourth-Largest Stock MarketAn Isolated Israel Doubles Down on War in Gaza — At All CostsNetflix Pays $5 Billion for ‘Raw’ in Bet on Live EventsHong Kong Stocks at 36% Discount Show Tru